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Background: Head and neck paragangliomas are tumors associated with the parasympathetic nerve system and
typically show an indolent growth pattern. Therefore a conservative management strategy is considered in selected
cases.
Methods and results: We present a case of a female patient who presented in 2003 with bilateral carotid body
tumors and a tympanic tumor, associated with a mutation in the succinate dehydrogenase -sub-unit-D (SDHD). She
was operated on the right carotid body tumor and the tympanic tumor. Thereafter the follow-up was performed
with MR examinations at 2-year intervals. After an initial stable phase, over the last 3 years a spontaneous near-total
regression of the contralateral carotid body tumor was observed, with only subtle rest-abnormalities visible in 2011.
Conclusions: The present case underlines the indolent growth pattern of head and neck paragangliomas and for
the first time describes a rare manifestation of spontaneous regression of a carotid body tumor. The literature was
reviewed to discuss this phenomenon.
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Head and neck paragangliomas (HNPGL) are usually be-
nign, slow-growing tumors associated with the parasym-
pathetic nerve system. Common sites include the carotid
body, the temporal bone, and the vagal body [1]. The
majority of patients presents as apparently sporadic
patients, whereas 10% to 20% of patients report a positive
family history [2,3]. Multiple paragangliomas may occur
in up to 40% of patients [4]. In the Netherlands the
majority of cases are related to mutations in the gene
encoding for the oxidative chain protein succinate
dehydrogenase-sub-unit-D (SDHD) [5]. In the neck, a
paraganglioma presents as a non-tender mass or as a cause
of lower cranial nerve palsy due to local compression. In
the temporal bone, the first symptom of paragangliomas is* Correspondence: S.Hammer@lumc.nl
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reproduction in any medium, provided the orusually pulsating tinnitus, due to the hypervascular nature
of the tumor. In follow-up about 60% of the HNPGL do
not exhibit growth, and if they do it typically is in an in-
dolent growth pattern with a median tumor double time
of 4.2 years [6]. Diagnosis is generally made through a
combination of clinical findings and magnetic resonance
imaging (MRI) studies. Treatment considerations include
the nature of the tumor (malignant or benign), the loca-
tion, vasculature encasement, the extent, and growth rate
[6,7]. Treatment modalities include surgery or radiother-
apy/surgery; treatment of choice for carotid body tumors
is surgical resection. However, because of the slow growth
rate and potential treatment-related injury to the neigh-
boring vessels and nerves, a conservative management
strategy (wait-and-scan policy) should be considered [6].Case presentation
In 2003 a 32-year-old female patient was referred to our
institution after magnetic resonance imaging (MRI)al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Transverse gadolinium-enhanced 3D time of flight
magnetic resonance angiography images at baseline in 2004
show the bilateral carotid body tumors (arrows).
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carotid body tumors. She had discovered a swelling in
the right neck since 6 months before, and only after
questioning mentioned a long-existing pulsatile tinnitus
on the right side. The family history for paragangliomas
was positive: her father and uncle were affected.
Physical examination revealed a small reddish tumor
in the right middle ear, with positive Brown’s sign and a
tumor in the right neck at the level of the hyoid bone;
on the left side there was no palpable lesion. The lower
cranial nerves were intact and the hearing was normal.
In general examination, the patient was all-over obese
(weight 121 kg, length 1.75 m, body mass index 39.5),
blood pressure was 130/70 mm Hg, pulse rate 80/min.
There were no other abnormalities. Urinary excretion
(24-h sample) of catecholamines was repeatedly normal.Figure 2 Transverse gadolinium-enhanced 3D time-of-flight magnetic
the carotid body tumor on the left in 2006 (A), unchanged in 2008 (B
regression in 2011 (D). On the image only a subtle linear enhancement iGermline mutation analysis in DNA from a blood sam-
ple demonstrated a mutation in SDHD (P-Asp92Tyr).
MRI including a gadolinium-enhanced 3D time-of-
flight MR angiography sequence [8] was acquired at our
institution in April 2004, and revealed hypervascular en-
hancing lesions in the carotid bifurcation bilaterally,
consistent with carotid body tumors. The maximum
transverse diameter was 23 mm on the right and 12 mm
on the left (Figure 1). A tympanic tumor was identified
on the right side.
The right carotid body tumor was surgically resected
in 2004, followed by extirpation of the tympanic tumor
in 2005. No radiotherapy was applied. There were no
complications from the surgical procedures. In the
postoperative phase a severe obstructive sleep apnea
syndrome (OSAS) was diagnosed, for which she started
continuous positive airway pressure (CPAP) therapy.
In 2005 she started thyroid hormone suppletion for
Hashimoto disease. Between 2005 and 2008, the patient
intentionally lost weight from 136 kg to 93 kg, because
of a pregnancy wish which was eventually unsuccessful.
During follow-up the patient regained bodyweight in
2010 to 129 kg. In 2011 she suffered anamnestically
from a transient ischemic attack (with no abnormal-
ities on imaging studies), after which she started statin
treatment and therapy with carbaselate calcium and
dipyridamole.
Follow-up MRI was performed with 2-year intervals
(Figure 2), and showed no evidence of recurrence on the
operated sites. Between 2004 and 2008 there were no
changes in size and enhancement pattern of the left
carotid body tumor and therefore surgical resection was
considered unnecessary. Unexpectedly, in 2010, the
tumor was significantly smaller, and showed reduced
enhancement in the center of the lesion, consistent
with necrosis. Follow-up examinations in June 2011 and
September 2011 showed nearly complete regression,resonance angiography images at subsequent intervals showing
), inhomogeneous ring-like enhancement in 2010 (C), and further
s noted, no evidence of an enhancing mass could be detected.
Hammer et al. World Journal of Surgical Oncology 2012, 10:218 Page 3 of 4
http://www.wjso.com/content/10/1/218leaving only minimal rest-abnormalities at the site of
the previous tumor. Other affected family members
showed no signs of regression during follow-up.
Discussion
We describe a patient with hereditary bilateral head and
neck paragangliomas who underwent surgical tumor re-
moval of a right carotid body tumor and a right tym-
panic tumor. During the 7-year follow-up, spontaneous
regression of the left carotid body tumor was noted,
after an initial period without any change in tumor size.
To the best of our knowledge, spontaneous involution of
head and neck paragangliomas has not been reported
before. In our referral center for paragangliomas, the
present case with spontaneous involution represents the
first from an estimated total of more than 400 followed
cases.
Spontaneous regression of tumors in general is a rare
phenomenon, although numerous cases and case series
can be found in the literature. Spontaneous remission of
tumors with a common neural crest embryological
origin as paragangliomas has been described as well.
Regression of pheochromocytomas after initial presenta-
tion with hypertensive crises or shock has been reported
[9-11], as well as spontaneous regression [12], Another
known entity is spontaneous regression in a subset of
pediatric neuroblastomas, especially those detected with
mass screening and with biologically favorable character-
istics [13,14].
Mechanism
The mechanism that accounts for the regression in the
present case can only be speculated upon. Below we dis-
cuss the general tumor regression hypotheses, including
biological (genetic, immunological), hormonal (such as
contraceptive use), vascular (vascular insufficiency/tumor
necrosis/spontaneous intratumoral vascular thrombosis),
and operative mechanisms [15].
Biological mechanisms related to tumor regression in-
clude genetic instability (telomerase inhibition) and pro-
grammed cell death, which has been described for
neuroblastomas [16,17]. The specific SDHD mutation in
the present case (p.Asp92Tyr), however, is relatively com-
mon - as it is found in almost 70% of 690 Dutch SDH-
gene mutation carriers [5] and has not been reported
to be associated with spontaneous tumor regression
before.
Although changes in body weight may go with changes
in catecholamine levels, we found no evidence for such
changes in our patient, neither after the start of CPAP
treatment for OSAS. Therefore a hormonal mechanism
for tumor regression seems unlikely.
Vascular mechanisms may be due to changes in tumor
angiostructure, and have been reported in spontaneousregressed (biologically favorable) neuroblastomas [18].
Such vascular mechanism could have explained the re-
gression in the present case, although we have no sup-
portive biomarkers for this hypothesis.
Operative mechanisms include regression of a tumor
after biopsy, which has been described in patients with
Merkel cell tumors [19,20], and involution of metastases
after resection of a primary tumor, recently described in
a patient with lung metastases of hepatocellular carcin-
oma [21]. Another example comes from a patient with
three hemangioblastomas (not related to Von Hippel-
Lindau disease), of which two regressed completely 6
months after surgical resection of the first tumor [22].
The authors hypothesized that the resected tumor may
have been supportive for the existence of the other two.
Furthermore, in two patients with neurofibromatosis
type 2 and bilateral vestibular schwannomas, spontan-
eous regression after resection of the contralateral tumor
was reported [23]. In this paper, one patient showed an
initial increase in tumor size, directly after resection of
the contralateral schwannoma. Afterwards, a gradual
decrease in tumor size was objectified from 6 months
postoperatively. Tumor size increased initially in the
second patient as well, whereas a decrease in tumor
size was noted from approximately 60 months [23]. A
similar mechanism may explain the regression of the
left carotid body tumor after initial resection of the
carotid body tumor on the right in our case.
Although the present case describes spontaneous invo-
lution, surgical resection is the favored treatment in ca-
rotid body tumors. Nevertheless, resection is associated
with complications such as cranial nerve impairment,
stroke, or partial scarification of the carotid arteries [24].
Conclusions
In conclusion, the present case underlines the indolent
growth pattern of head and neck paragangliomas and
for the first time describes a rare manifestation of invo-
lution of a carotid body tumor.
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